Aurobindo Pharma Limited (NSE:AUROPHARMA) Q4 FY23 Earnings Concall dated May. 28, 2023. Corporate Participants: Deepti Thakur -- Investor Relations & Corporate Communications
Aurobindo Pharma Limited (AUROPHARMA) Q4 FY23 Earnings Concall Transcript
Categories
Medical Distribution
Shalby Ltd. Q3FY23; 18% Growth in Profits
Shalby Ltd.‘s revenues in Q3FY23 rose 25% to ₹ 2,067 millions. Consolidated Profit After Tax came at ₹ 153 millions showcasing an
Prevest Denpro Limited Q3 FY22 Earnings Conference Call Insights
https://www.youtube.com/watch?v=ECd3N-qiOMo Key highlights from Prevest Denpro Limited (PREVEST) Q3 FY22 Earnings Concall Q&A Highlights: Pranay Jain from Dealwell Capital asked that since
Dr. Reddy’s Laboratories (DRREDDY) Q3 FY22 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE:DRREDDY) Q3 FY22 Earnings Concall dated Jan. 28, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag
How Cipla performed in Q2 2022
The pharma giant Cipla (NSE: CIPL) reported its second-quarter 20223 earnings results on Tuesday after market hours. The total revenue increased by
IPO Alert: Wellness Forever Medicare files papers for a public listing
The Indian pharmaceutical industry is the world’s third-largest by volume and 14th largest by value. The turnover of the country’s pharmaceutical market
IPO Alert: Healthium Medtech files draft papers as it looks to raise funds
Healthcare is amongst the fastest-growing sectors in India, both in terms of revenue and employment. The Indian healthcare industry is expected to
Aurobindo Pharma Ltd (AUROPHARMA) Q3 FY21 Earnings Concall Transcript
Aurobindo Pharma Ltd (NSE:AUROPHARMA) Q3 FY21 earnings concall dated Feb. 10, 2021. Corporate Participants: Krishna Kiran -- Manager of Investor Relations Santhanam
Dr.Reddy’s Laboratories Ltd (DRREDDY) Q3 FY21 Earnings Concall Transcript
Dr.Reddy's Laboratories Ltd (NSE: DRREDDY) Q3 FY21 earnings Concall dated Jan. 29, 2021. Corporate Participants: Amit Agarwal -- Head of Investor Relations